Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Postoperative Complications | 16 | 2022 | 1615 | 2.070 |
Why?
|
| Colectomy | 10 | 2022 | 64 | 2.060 |
Why?
|
| Elective Surgical Procedures | 6 | 2022 | 95 | 1.370 |
Why?
|
| Blood Transfusion | 2 | 2022 | 205 | 0.860 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2022 | 59 | 0.840 |
Why?
|
| Colonic Neoplasms | 3 | 2021 | 299 | 0.830 |
Why?
|
| Quality Improvement | 5 | 2022 | 413 | 0.780 |
Why?
|
| Peripheral Arterial Disease | 4 | 2016 | 83 | 0.780 |
Why?
|
| Lower Extremity | 4 | 2016 | 153 | 0.760 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 117 | 0.740 |
Why?
|
| Diverticulitis, Colonic | 1 | 2020 | 10 | 0.720 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 213 | 0.680 |
Why?
|
| Quality Indicators, Health Care | 3 | 2016 | 136 | 0.670 |
Why?
|
| Perineum | 2 | 2017 | 11 | 0.670 |
Why?
|
| Colostomy | 1 | 2019 | 15 | 0.670 |
Why?
|
| Hernia, Ventral | 1 | 2019 | 35 | 0.650 |
Why?
|
| Cystic Fibrosis | 1 | 2022 | 283 | 0.630 |
Why?
|
| Laparoscopy | 5 | 2020 | 237 | 0.590 |
Why?
|
| Retrospective Studies | 16 | 2022 | 7277 | 0.570 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 561 | 0.570 |
Why?
|
| Patient Readmission | 3 | 2019 | 267 | 0.530 |
Why?
|
| Myocutaneous Flap | 1 | 2015 | 6 | 0.520 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2015 | 20 | 0.520 |
Why?
|
| Abdomen | 1 | 2015 | 80 | 0.500 |
Why?
|
| Vascular Surgical Procedures | 4 | 2016 | 168 | 0.460 |
Why?
|
| Rectum | 3 | 2019 | 62 | 0.450 |
Why?
|
| Wound Healing | 1 | 2015 | 260 | 0.450 |
Why?
|
| Reoperation | 4 | 2020 | 467 | 0.440 |
Why?
|
| Treatment Outcome | 16 | 2022 | 7029 | 0.430 |
Why?
|
| Risk Factors | 11 | 2022 | 5731 | 0.430 |
Why?
|
| Humans | 32 | 2022 | 68618 | 0.420 |
Why?
|
| Healthcare Disparities | 3 | 2022 | 378 | 0.420 |
Why?
|
| Middle Aged | 20 | 2022 | 21147 | 0.380 |
Why?
|
| Colitis, Ulcerative | 3 | 2019 | 53 | 0.350 |
Why?
|
| United States | 12 | 2022 | 7367 | 0.350 |
Why?
|
| Aged | 14 | 2022 | 14862 | 0.330 |
Why?
|
| Proctocolectomy, Restorative | 2 | 2019 | 3 | 0.320 |
Why?
|
| Endovascular Procedures | 4 | 2016 | 366 | 0.320 |
Why?
|
| Length of Stay | 4 | 2022 | 780 | 0.310 |
Why?
|
| Rectal Neoplasms | 2 | 2019 | 75 | 0.290 |
Why?
|
| Multivariate Analysis | 5 | 2015 | 1046 | 0.270 |
Why?
|
| Adult | 8 | 2022 | 21403 | 0.260 |
Why?
|
| Male | 21 | 2021 | 37321 | 0.260 |
Why?
|
| Chi-Square Distribution | 6 | 2016 | 546 | 0.250 |
Why?
|
| Carotid Artery Diseases | 2 | 2016 | 83 | 0.240 |
Why?
|
| Female | 19 | 2021 | 38074 | 0.240 |
Why?
|
| Endarterectomy, Carotid | 2 | 2016 | 110 | 0.240 |
Why?
|
| Odds Ratio | 6 | 2016 | 880 | 0.230 |
Why?
|
| Cost Savings | 2 | 2022 | 110 | 0.230 |
Why?
|
| Comorbidity | 4 | 2015 | 1426 | 0.230 |
Why?
|
| Laparotomy | 2 | 2020 | 65 | 0.210 |
Why?
|
| Fever | 1 | 2022 | 96 | 0.200 |
Why?
|
| Linear Models | 2 | 2021 | 521 | 0.190 |
Why?
|
| Genes, MHC Class I | 1 | 2021 | 14 | 0.190 |
Why?
|
| Genes, MHC Class II | 1 | 2021 | 29 | 0.190 |
Why?
|
| Patient Selection | 4 | 2020 | 592 | 0.190 |
Why?
|
| Immunophenotyping | 1 | 2021 | 110 | 0.190 |
Why?
|
| Time Factors | 8 | 2018 | 4655 | 0.190 |
Why?
|
| Diverticulitis | 1 | 2020 | 6 | 0.180 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 80 | 0.180 |
Why?
|
| Immunity | 1 | 2021 | 67 | 0.180 |
Why?
|
| Incidence | 2 | 2022 | 1603 | 0.180 |
Why?
|
| Anastomotic Leak | 1 | 2020 | 11 | 0.180 |
Why?
|
| Fibrosis | 1 | 2022 | 371 | 0.180 |
Why?
|
| Logistic Models | 5 | 2014 | 1420 | 0.180 |
Why?
|
| Peritonitis | 1 | 2020 | 46 | 0.180 |
Why?
|
| Adalimumab | 1 | 2019 | 16 | 0.170 |
Why?
|
| Gastric Fistula | 1 | 2019 | 6 | 0.170 |
Why?
|
| Ileostomy | 1 | 2019 | 14 | 0.170 |
Why?
|
| Pancreatic Fistula | 1 | 2019 | 23 | 0.170 |
Why?
|
| Colorectal Surgery | 1 | 2019 | 11 | 0.170 |
Why?
|
| Hospitals | 1 | 2022 | 265 | 0.170 |
Why?
|
| Intestinal Fistula | 1 | 2019 | 26 | 0.170 |
Why?
|
| Anticoagulants | 1 | 2022 | 356 | 0.170 |
Why?
|
| Crohn Disease | 1 | 2019 | 38 | 0.170 |
Why?
|
| Robotic Surgical Procedures | 1 | 2020 | 49 | 0.170 |
Why?
|
| Adolescent | 2 | 2022 | 8912 | 0.170 |
Why?
|
| Colon, Sigmoid | 1 | 2019 | 13 | 0.170 |
Why?
|
| Socioeconomic Factors | 1 | 2022 | 955 | 0.170 |
Why?
|
| Neoplasm Staging | 2 | 2019 | 800 | 0.170 |
Why?
|
| Abdominal Wall | 1 | 2019 | 20 | 0.160 |
Why?
|
| Age Factors | 2 | 2021 | 1864 | 0.160 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 104 | 0.160 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 329 | 0.160 |
Why?
|
| Nerve Block | 1 | 2019 | 55 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 266 | 0.160 |
Why?
|
| Propensity Score | 2 | 2015 | 117 | 0.160 |
Why?
|
| Gene Expression | 1 | 2021 | 770 | 0.160 |
Why?
|
| Prospective Studies | 4 | 2019 | 3705 | 0.150 |
Why?
|
| Demography | 2 | 2017 | 279 | 0.150 |
Why?
|
| Ultrasonography, Interventional | 2 | 2019 | 119 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2022 | 1553 | 0.150 |
Why?
|
| Phenotype | 1 | 2021 | 947 | 0.150 |
Why?
|
| Aged, 80 and over | 6 | 2019 | 4848 | 0.150 |
Why?
|
| Chronic Disease | 1 | 2022 | 1330 | 0.150 |
Why?
|
| Pain Management | 1 | 2019 | 186 | 0.150 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 214 | 0.140 |
Why?
|
| Macrophages | 1 | 2021 | 647 | 0.140 |
Why?
|
| Sex Factors | 1 | 2021 | 1266 | 0.140 |
Why?
|
| Regional Medical Programs | 1 | 2016 | 22 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 446 | 0.140 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2014 | 85 | 0.140 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2016 | 8 | 0.140 |
Why?
|
| Intermittent Claudication | 1 | 2016 | 31 | 0.140 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 475 | 0.140 |
Why?
|
| Postoperative Hemorrhage | 1 | 2016 | 69 | 0.130 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 49 | 0.130 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 79 | 0.130 |
Why?
|
| Renal Artery | 1 | 2015 | 29 | 0.130 |
Why?
|
| Urological Agents | 1 | 2015 | 7 | 0.130 |
Why?
|
| Aneurysm | 1 | 2015 | 53 | 0.130 |
Why?
|
| Iliac Aneurysm | 1 | 2015 | 7 | 0.130 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 104 | 0.130 |
Why?
|
| Urinary Retention | 1 | 2015 | 20 | 0.130 |
Why?
|
| Stents | 3 | 2015 | 657 | 0.130 |
Why?
|
| Ischemia | 1 | 2016 | 229 | 0.130 |
Why?
|
| Intraoperative Care | 1 | 2015 | 91 | 0.120 |
Why?
|
| Patient Discharge | 2 | 2014 | 294 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2015 | 163 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2015 | 141 | 0.120 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2015 | 139 | 0.120 |
Why?
|
| Vascular Grafting | 1 | 2014 | 12 | 0.120 |
Why?
|
| Urinary Catheterization | 1 | 2014 | 27 | 0.110 |
Why?
|
| Femoral Artery | 1 | 2014 | 139 | 0.110 |
Why?
|
| Preexisting Condition Coverage | 1 | 2013 | 4 | 0.110 |
Why?
|
| Angioplasty, Balloon | 1 | 2014 | 110 | 0.110 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 43 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2016 | 346 | 0.110 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 85 | 0.110 |
Why?
|
| Urinary Tract Infections | 1 | 2014 | 71 | 0.110 |
Why?
|
| Patient Admission | 1 | 2013 | 99 | 0.110 |
Why?
|
| Angioplasty | 1 | 2013 | 118 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2015 | 2358 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 504 | 0.100 |
Why?
|
| Databases, Factual | 4 | 2016 | 622 | 0.100 |
Why?
|
| Cross Infection | 1 | 2014 | 195 | 0.100 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2013 | 134 | 0.100 |
Why?
|
| Young Adult | 1 | 2022 | 5717 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 468 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 504 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 3259 | 0.070 |
Why?
|
| Survival Rate | 2 | 2019 | 1056 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2016 | 2007 | 0.060 |
Why?
|
| Hospital Mortality | 2 | 2015 | 384 | 0.060 |
Why?
|
| Stroke | 1 | 2013 | 2163 | 0.050 |
Why?
|
| Ileitis | 1 | 2019 | 3 | 0.040 |
Why?
|
| Budesonide | 1 | 2019 | 10 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2020 | 106 | 0.040 |
Why?
|
| Azathioprine | 1 | 2019 | 16 | 0.040 |
Why?
|
| Ileus | 1 | 2019 | 7 | 0.040 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2019 | 22 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2019 | 17 | 0.040 |
Why?
|
| Proctoscopy | 1 | 2019 | 4 | 0.040 |
Why?
|
| Anesthetists | 1 | 2019 | 5 | 0.040 |
Why?
|
| Intestinal Obstruction | 1 | 2019 | 36 | 0.040 |
Why?
|
| Abdominal Muscles | 1 | 2019 | 25 | 0.040 |
Why?
|
| Morphine | 1 | 2019 | 76 | 0.040 |
Why?
|
| Mortality | 1 | 2019 | 163 | 0.040 |
Why?
|
| Surgeons | 1 | 2019 | 68 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 125 | 0.040 |
Why?
|
| Endosonography | 1 | 2019 | 177 | 0.040 |
Why?
|
| Colitis | 1 | 2019 | 156 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 168 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 67 | 0.040 |
Why?
|
| Benchmarking | 1 | 2016 | 91 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 514 | 0.030 |
Why?
|
| Aortic Rupture | 1 | 2015 | 32 | 0.030 |
Why?
|
| Pelvis | 1 | 2015 | 38 | 0.030 |
Why?
|
| Iliac Artery | 1 | 2015 | 44 | 0.030 |
Why?
|
| Critical Illness | 1 | 2016 | 191 | 0.030 |
Why?
|
| Vascular Closure Devices | 1 | 2014 | 1 | 0.030 |
Why?
|
| Boston | 1 | 2014 | 35 | 0.030 |
Why?
|
| Punctures | 1 | 2014 | 35 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2015 | 100 | 0.030 |
Why?
|
| Vascular System Injuries | 1 | 2014 | 20 | 0.030 |
Why?
|
| Hematoma | 1 | 2014 | 47 | 0.030 |
Why?
|
| Aneurysm, False | 1 | 2014 | 60 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2013 | 43 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2015 | 186 | 0.030 |
Why?
|
| Thrombosis | 1 | 2014 | 218 | 0.030 |
Why?
|
| Registries | 1 | 2016 | 733 | 0.030 |
Why?
|
| Medicare | 1 | 2015 | 319 | 0.030 |
Why?
|
| Emergencies | 1 | 2013 | 107 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 306 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2014 | 328 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1465 | 0.030 |
Why?
|
| Hospitalization | 1 | 2018 | 978 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 1515 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 951 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2013 | 311 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 2324 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 2093 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2077 | 0.020 |
Why?
|